1. HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes
   Vic Hart et al, 2020, Oncotarget CrossRef
2. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
   Mario Campone et al, 2021, European Journal of Cancer CrossRef